Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

Keyphrases

• Uganda 100%
• Cryptococcal Meningitis 100%
• Highly Active Antiretroviral Therapy (HAART) 100%
• AIDS/HIV 60%
• Confidence Interval 60%
• Odds Ratio 60%
• Africa 20%
• Immune Reconstitution 20%
• Prospective Observational Study 20%
• Cause of Death 20%
• Protein Level 20%
• Ugandan 20%
• Associated Complications 20%
• Amphotericin B 20%
• High Mortality 20%
• Survival Rate 20%
• Antiretroviral Therapy Initiation 20%
• Sterilization 20%
• High Mortality Rate 20%
• Lumbar Puncture 20%
• WBC Count 20%
• Virus Therapy 20%
• Kampala Uganda 20%
• Proximate Cause 20%
• Antiretroviral Naïve 20%

Nursing and Health Professions

• Highly Active Antiretroviral Therapy 100%
• Cryptococcal Meningitis 100%
• Odds Ratio 60%
• Confidence Interval 60%
• Human Immunodeficiency Virus 40%
• Leukocyte Count 20%
• Virotherapy 20%
• Instrument Sterilization 20%
• Mortality Rate 20%
• Survival Rate 20%
• Acquired Immune Deficiency Syndrome 20%
• Amphotericin B 20%
• Immune Reconstitution Inflammatory Syndrome 20%
• Lumbar Puncture 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cryptococcal Meningitis 100%
• HIV 40%
• Mortality Rate 20%
• Survival Rate 20%
• Acquired Immune Deficiency Syndrome 20%
• Amphotericin B 20%
• Virotherapy 20%
• Immune Reconstitution Inflammatory Syndrome 20%